Antibiotics for Appendicitis: 37.8% Recurrence, 44.3% Appendectomy at 10 Years
The APPAC randomized clinical trial provides a 10-year follow-up analysis of patients with uncomplicated acute appendicitis treated with antibiotics versus appendectomy. Conducted across six Finnish hospitals, 530 patients aged 18-60 years were randomized to either open appendectomy or a regimen of intravenous ertapenem sodium followed by oral levofloxacin and metronidazole. The primary endpoint was the 10-year recurrence rate of appendicitis in the antibiotic group, which was 37.8% (95% CI, 31.6%-44.1%). The cumulative appendectomy rate in this group was 44.3% (95% CI, 38.2%-50.4%). Secondary endpoints included a comparison of complication rates, which were significantly lower in the antibiotic group (8.5%) compared to the appendectomy group (27.4%, P<.001). Quality of life assessments showed no significant difference between the two groups (P=0.18). Safety profiles favored antibiotics, with fewer complications reported. These findings suggest that antibiotics remain a viable option for treating uncomplicated acute appendicitis, offering a non-surgical alternative with lower complication rates.